Clinical Trial Detail

NCT ID NCT02518750
Title Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors St. Jude Children's Research Hospital
Indications

lymphoma

acute lymphoblastic leukemia

Therapies

Bortezomib + Dexamethasone + Panobinostat

Pegaspargase

Mercaptopurine

Nelarabine

Mitoxantrone

Vincristine Sulfate

Cyclophosphamide + Etoposide

Cytarabine + Methotrexate + Prednisone

Clofarabine

Age Groups: adult child

No variant requirements are available.